D2 - How do drugs work Flashcards

1
Q

drugs are

A

Drugs - small molecules that bind to a large biological molecule - macromolecule

- Ligands - molecule that binds to another molecule (or ion)
- Biological macromolecule is usually the target 
- Not all drugs work this way - Some drugs neutralise toxins 
- Large biological molecular target - usually small compared to their target 
- Some drugs - proteins and antibodies - large molecules being used as drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Lipids

A

Lipids - not very large, create assemblies eg. Cell membranes - which behave as one large molecule

- Drugs acting on targets inside a cell have to get through a cell membrane 
- Cell membrane has a hydrophobic interior 
- Water doesn’t pass passively through a cell membrane 
- Charged molecules don’t pass through a cell membrane
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Carbohydrates

A
  • Polymers of carbohydrates
    • Usually attached to proteins or lipids
    • Surface of cells is adorned with carbohydrates - surface is covered
    • Glycoproteins, glycosphingolipids (glycoconjugates)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Nucleic acids

A
  • RNA and DNA

- Anti cancer drugs interact with this

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

proteins

A
- 4 types 
		○ Transporters 
			§ Transport molecules eg. from one side of a cell membrane to the other 
		○ Structural 
			§ Give structure to the inside of a cell 
			§ Collagen 
		○ Enzymes 
			§ Catalyse chemical reactions 
		○ Receptors 
			§ Involved in chemical signalling 
			§ Regulate processes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Induced fit

A
  • Drugs and macromolecular targets are conformationally flexible - Macromolecule in particular
    ○ Adopting different shapes through rotation about single bonds
    ○ Drug is also conformationally flexible
    ○ Some reorganisation of target structure upon binding
    • Maximises binding interactions - lowers energy of complex formed
    • Change in shape of macromolecule - important to pharmacological effect - especially when the target is a receptor
    • Change in shape of drug as well
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Molecular recognition

A
  • Drugs usually bind their targets selectively through molecular recognition - complementary non-covalent binding interactions (intermolecular forces)
    ○ Some drugs form covalent bonds - but the binding process usually begins with non-covalent forces - this is rare
    ○ One molecule recognising another and then forming a complex
    ○ Process is reversible - binding can occur and than disassociate again
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Binding regions

A
  • Drug has functional groups that has complimentary interaction with binding site
    • Needs to be complementarity of
      ○ shape of the molecule and binding site
      ○ Charge distribution - how the electron density is distributed in the molecule
    • Binding site - pocket or cleft in surface of protein
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Part of the drug sticking out from the binding site

A
  • Improves pharmacokinetic properties eg. Water solubility, permeate cell membrane, prevent metabolism
    • Pharmacophore - the part that is involved in binding
      The combined features of a drug that binds to a target and causes biological effect
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Energetics of binding process

A
  • Equilibrium process
    • Position of equilibrium will depend on the difference in free energy of the complex and free molecules
    • Occurring in solution - solvated in water molecules
    • Dissociation constant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Difference in free energy

A
  • Made up of two components
    ○ Enthalpy
    ○ Entropy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Ionic

A
  • Longest range/occurs over the longest distance
    ○ Important as drug enters the binding site
    • Drugs and targets are moving around through Brownian motion
    • Collisions occur frequently in cells
    • Eg. Drug positive and target negative charge - honing in on binding site
    • Strength of interaction is inversely proportional to the target
    • Ion pairs are non-directional in binding
    • Proteins involving metals have directional binding
      ○ Because the nature of the interaction involves the overlap of a lone pair of electrons with an empty orbital in the metal ion
      ○ Orbitals have a defined shape - binding is directional

Ionic interactions are weak when there are polar molecules around - eg. Water

If the interaction happens in a hydrophobic pocket of a protein - stronger

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
  • Basic Amino acids
A

○ React with a proton in neutral form and form positive charged species

- Acidic amino acid residues - give up proton at physiological pH eg. Aspartate, glutamate
- Backbone of DNA and RNA is negatively charged 
- Polar headgroup of phospholipid making up lipid bilayer of a cell membrane
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Ionisable functional groups in drugs

A
  • Either have a permanent charge or can ionise at ph 7
    • Carboxylic acids and amines
    • Carboxylic acids
      ○ Ibuprofen - carboxylic acid
      ○ Advil - absorbed more rapidly - sodium salt of ibuprofen - dissolves faster in water
      ○ Equilibrium determined by pH of blood
      § Carboxylic acid present as carboxylate
      § Improved water solubility
      § Likely that there will be ionic interaction with target
      ○ Non-ionised form could allow drug to get through cell membrane
      ○ Once inside a cell, can revert back to deprotonated form
    • Amines
      ○ pseudoephedrine hydrochloride (Sudafed)
      ○ Can have a reduction reaction and be made to methamphetamine
      ○ Form that predominates at ph 7 is ionised form
      § Protonated form has better water solubility and can take part in ionic interactions
      Deprotonated form will be important for getting through a cell membran
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

not ionisable functional groups

A
  • Amides and alcohols are not ionised at pH 7
    ○ Amides have a nitrogen atom with a lone pair of electrons
    § Get delocalised onto carbonyl oxygen
    • Phenols and anilines are predominantly unionised
      Phenols are more acidic then alcohols but not enough to be deprotonated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Hydrogen bonding

A
  • Properties of water
    • Hydrogen shared between x and y
    • X is very electronegative with lone pairs of electrons
    • Directional
    • Hydrogen bonds arises when there is
      ○ Orbital with lone pair of electrons - hydrogen bond acceptor
      ○ Electronegative atom - oxygen or nitrogen with a covalent bond to hydrogen (sigma bond)
      ○ Anti bonding orbital will be associated with the sigma bond
17
Q

Salt bridges

A
  • Negatively charged functional group with lone pair of electrons
    • Between drugs, between protein residues, aspartate and glutamate residues holding proteins together
18
Q

Dispersion forces

A
  • Occur between all molecules
    • Most important in hydrophobic parts of molecules (non polar)
    • Weakest type of non covalent interaction
    • In a polar environment
      ○ dispersion forces between drug and water molecules are negligible
      ○ Dispersion forces between hydrophobic molecules are significant
    • Weak - needing close contact between molecules
    • Shape complementarity is necessary
19
Q

Water

A
  • Binding interactions occurring in a polar solvent
    • Drug and protein molecule are solvated
    • Forming hydrogen binds with drugs and binding site
    • Ionic interactions and hydrogen bonds form with water - inhibit it forming at the binding site - costs energy because hydrogen bonds are favourable interactions
      ○ Interactions with water have to be broken to create interaction with binding site
      ○ Less likely to be energetically favourable
20
Q

Increasing heart rate

A
  • Chronic low heart rate
    • Endogenous molecules - hormones that increase heart rate - eg. Adrenaline
      ○ Too many side effects
      ○ CNS effects
      ○ Constricts arteries and veins around the heart
    • Isoprenalin
      ○ A1 causes vasoconstriction
      ○ B adrenoceptor in the heart increases heart rate
      ○ Isoprenalin
      § Substitution of a methyl to an isopropyl
      § Isopropyl group has stearic clash with receptor pocket of A1 - doesn’t fit in the binding site - no longer causes vasoconstriction - creating selectivity of the target
21
Q

Endogenous molecules - hormones that increase heart rate - eg. Adrenaline

A

○ Too many side effects
○ CNS effects
○ Constricts arteries and veins around the heart

22
Q
  • Isoprenalin
A

○ A1 causes vasoconstriction
○ B adrenoceptor in the heart increases heart rate
○ Isoprenalin
§ Substitution of a methyl to an isopropyl
§ Isopropyl group has stearic clash with receptor pocket of A1 - doesn’t fit in the binding site - no longer causes vasoconstriction - creating selectivity of the target

23
Q

High energy conformation

A
  • Maybe in protein
    • Molecules are flexible - rotation about single bonds
    • Unstable
    • Results from repulsion - bringing bonds too close together and the electron density causes repulsion
24
Q

ACE inhibitors

A
  • ACE = angiotensin-converting enzyme
    • Used for treatment of high blood pressure
    • Lowers energy of molecule by creating stronger ionic interaction
    • Cilazapril
25
Q

Entropy

A
  • Measure of disorder
    • Disordered state is more energetically favourable
    • More negative - more stable the complex is
    • Negative entropy change - does not favour formation of complex
    • Going from two molecules to one - goes against entropy (double degree of freedom with two separate molecules)
    • Entropy must be lost when a drug binds its target - energy is lost
26
Q

If a drug molecule is conformationally flexible

A
  • When it binds, it adopts a more restricted conformation - loss of entropy due to fewer degrees of freedom (flexibility)
    • Loss of entropy, not energetically favourable
    • Solution: Start with a rigid molecule to begin with - has less entropy to lose when binding to the target, less energetically unfavourable
      ○ Aromatic planar rings and double and single bonds increase rigidity

Drugs made rigid -aromatic rings, double and triple bonds

27
Q

Hydrophobic effect

A
  • Hydrophobic parts of drugs
    • If a drug dissolves in water with a hydrophobic region - water molecules must become more ordered around it
    • When alongside a hydrophobic region - loses entropy
    • Structured shell of water - loss of entropy
    • Hydrophobic binding region on macromolecular target
    • When the drug forms a complex - ordered water molecules are released into the solvent - entropy increases - only type of entropy that can increase when a drug binds to a target
    • Energetically favourable because binding creates gain in entropy
      ○ Although some energy is lost by the drug and target binding and forming one entity
      ○ This is the only way drug binding can create a gain in entropy
    • When a non-polar molecule is dissolved in water, more structures water-water interactions are formed in the solvent shell to compensate for the weaker interactions between solute and water
    • Increased organisation of water molecules around the solvent shell creates a decrease in entropy
    • Non-polar surface area is reduced when two molecules come together
      ○ Favourable entropy of association
    • Entropy of solvation can be positive or negative
      ○ Polarity must be balanced in drugs. Fatty drugs have poor water solubility and often off-target effects (side effects/toxicity)
    • Drug has to be water soluble - cant be too fatty or it doesn’t get absorbed and distributed
    • Hydrophobic drugs associated with unwanted side effects
      Will stick to other hydrophobic targets
28
Q
  • Amphotericin
A

Drugs that target cell membranes
- Cell membranes - polar head groups and hydrophobic interior
- Amphotericin
○ used to treat fungal infections interacts with cell membrane of a fungi
○ Amphoteric - reacts with both acid and base
§ Acidic and basic functional group
○ Amphiphilic - loving and hating water
○ Targets Ergosterol - on the cell membrane of fungi - similar to cholesterol on human cells
§ Ergosterol molecules clump together to form a pore through the cell membrane on the fungi - causes apoptosis
§ Fungal cells have high osmolarity inside the cell
□ Internal pressure
§ Selective for fungal cells because they have ergosterol and we have cholesterol and it does not bind cholesterol

29
Q

Drugs that target DNA

A
  • Most commonly used to treat cancer
    • DNA bases bind to one another and are stacked on top of one another
    • Intercalating agents
      ○ Have planar rigid structure like DNA bases
      ○ Hydrophobic core
      ○ Slip in between DNA bases and causes favourable binding interactions
      ○ Positively charged functional group that has an ionic interaction with the negatively charged phosphodiester backbone of the DNA
    • Daunorubicin
      ○ Binds and intercalates into DNA and changes shape - no longer recognised by enzymes that replicate DNA
      ○ transcription cannot occur - cancer cannot replicate
30
Q
  • Daunorubicin
A

○ Binds and intercalates into DNA and changes shape - no longer recognised by enzymes that replicate DNA
○ transcription cannot occur - cancer cannot replicate

31
Q

Drugs that target proteins

A
  • Most common drug targets
    • Amprenavir-HIV protease
      ○ Used to treat HIV to prevent aids
      ○ HIV-protease - produced by HIV virus
      § If you inhibit this, it stops it from replication
      § Functional as a homodimer
      § Active site - interface between the two proteins
      ○ Crystal of the protein in complex of the drug
      § Interrogated using x ray crystallography (taking a picture of a molecule)
      § Used to help design this drug - rational drug design
      § Empty site - catalytic site - molecule designed to fit in the site
    • Interaction between drug and protein
      ○ Hydrogen bond acceptors on protein - lone electron pairs
      ○ Drug has hydrogen bond donors
      ○ Hydrogen bond with alanine and peptide
32
Q

amprenavir

A
  • Amprenavir-HIV protease
    ○ Used to treat HIV to prevent aids
    ○ HIV-protease - produced by HIV virus
    § If you inhibit this, it stops it from replication
    § Functional as a homodimer
    § Active site - interface between the two proteins
    ○ Crystal of the protein in complex of the drug
    § Interrogated using x ray crystallography (taking a picture of a molecule)
    § Used to help design this drug - rational drug design
    § Empty site - catalytic site - molecule designed to fit in the site